Sanjiv Patel - Jan 16, 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: President and CEO, Director
Signature: /s/ Brian Adams, as attorney-in-fact
Stock symbol: RLAY
Transactions as of: Jan 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/18/2024, 04:19 PM
Previous filing: Sep 29, 2023
Next filing: Jul 1, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLAY	Common Stock	Award	$0	+762K	+45870.04%	$0.00	764K	Jan 16, 2024	Direct	F1, F2
holding	RLAY	Common Stock						675K	Jan 16, 2024	By The Patel Family Irrevocable Trust of 2019	F3
holding	RLAY	Common Stock						687K	Jan 16, 2024	By The SSP Irrevocable Trust of 2020	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F2	Includes 762,360 shares underlying RSUs.
F3	These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.